An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
-
Prepare for the Japanese Patent Opposition System Coming Soon – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0
The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule...
-
Review on Development of Orphan Drug for Rare disease
Pharma Live, , Intellectual Property Rights, 0
ABOUT AUTHORS:Kamshette Sharada*, Poul Bhagwat, Ghodke AmolDepartment of Quality Assurance,Maharashtra College of Pharmacy,Nilanga, Maharashtra, India.*[email protected] ABSTRACTSimply receiving a diagnosis...
-
The Importance of Contracts for Joint Infringement in Patent Cases – Courtesy (IP Litigation Current)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JUSTIN M. SOBAJE ON 19 MAY 2015POSTED IN DIVIDED INFRINGEMENT;DIVIDED INFRINGEMENT;PATENTS;PLEADINGS;SUPREME COURTIt has been about a year since the Supreme...
-
GW Pharmaceuticals Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy – Courtesy( Biospace)
Pharma Live, , Intellectual Property Rights, 0
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a...
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Telmisartan: no double-dipping says CJEU, as it avoids answering all the questions – Courtesy (The SPC Blog)
Pharma Live, , Intellectual Property Rights, 0
The Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK...
-
Patent Safe Harbor Applies To Supplemental New Drug Applications
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JACOB D. MOORE AND COURTENAY C. BRINCKERHOFF ON 21 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTOn May 13, 2015, the Federal Circuit confirmed...
-
Wyeth denied patent for cancer drug – Courtesy ( The Financial Express)
Pharma Live, , Intellectual Property Rights, 0
Wyeth, which was acquired by US- based pharma major Pfizer Inc, has suffered a major setback in India with...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)